Clintabs (Clindamycin) are indicated for the treatment of susceptible dental and skin infections, deep wounds and abscesses, and osteomyelitis in dogs.
In clinical trials, vomiting and diarrhea were occasionally observed. Do not use in animals with a history of hypersensitivity to clindamycin or lincomycin. Use with caution in patients with very severe renal disease and/or very severe hepatic disease.
Indications: Clintabs (brand of clindamycin hydrochloride) Tablets (for use in dogs only) are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below:
Contradictions: Clintabs Tablets are contraindicated in animals with a history of hypersensitivity to preparations containing clindamycin or lincomycin. Because of potential adverse gastrointestinal effects, do not administer to rabbits, hamsters, guinea pigs, horses, chinchillas or ruminating animals.
Adverse Reactions: Side effects occasionally observed in either clinical trials or during clinical use were vomiting and diarrhea
Duration: Treatment with clindamycin hydrochloride products may be continued up to a maximum of 28 days if clinical judgment indicates. Treatment of acute infections should not be continued for more than three or four days if no response to therapy is seen.
WARNINGS: Keep out of reach of children. Not for human use.